TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 104 filers reported holding TERNS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,331 | -18.3% | 195,442 | -21.3% | 0.00% | -100.0% |
| Q1 2024 | $1,629 | +197.3% | 248,304 | +193.6% | 0.00% | – |
| Q4 2023 | $548 | +100.0% | 84,582 | +55.7% | 0.00% | – |
| Q3 2023 | $274 | -88.1% | 54,327 | -79.3% | 0.00% | -100.0% |
| Q2 2023 | $2,301 | -63.7% | 262,918 | -50.8% | 0.00% | -66.7% |
| Q1 2023 | $6,332 | +20.4% | 534,760 | +3.5% | 0.00% | +50.0% |
| Q4 2022 | $5,261 | -99.9% | 516,739 | -21.6% | 0.00% | -50.0% |
| Q3 2022 | $3,882,000 | +11663.6% | 659,098 | +4921.7% | 0.00% | – |
| Q2 2022 | $33,000 | -28.3% | 13,125 | -14.5% | 0.00% | – |
| Q1 2022 | $46,000 | – | 15,352 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUPERSTRING CAPITAL MANAGEMENT LP | 956,542 | $6,514,051 | 8.21% |
| Vivo Capital, LLC | 6,182,992 | $42,106,176 | 3.89% |
| Soleus Capital Management, L.P. | 4,947,738 | $33,694,096 | 2.97% |
| ACUTA CAPITAL PARTNERS, LLC | 369,280 | $2,514,797 | 2.12% |
| GREAT POINT PARTNERS LLC | 1,149,406 | $7,827,455 | 1.50% |
| VR Adviser, LLC | 3,410,058 | $23,222,495 | 1.48% |
| Octagon Capital Advisors LP | 1,364,400 | $9,291,564 | 1.46% |
| Deep Track Capital, LP | 6,100,000 | $41,541,000 | 1.24% |
| Orbimed Advisors | 7,619,135 | $51,886,309 | 1.02% |
| Worth Venture Partners, LLC | 17,470 | $118,971 | 0.88% |